Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Versant Ventures

investment firm

About

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

  • Menlo Park,California,United States

Details

Industries
Financial Services,Health Care,Venture Capital
Founded date
Jan 1, 1999
Operating Status
Active
Legal Name
Versant Ventures
Investor Type
Venture Capital

Versant Ventures is a healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S., and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs.

Funds Raised

Announced Date Fund Name Money Raised
Apr 21, 2021 Versant Venture Capital VIII $560M
Apr 21, 2021 Versant Voyageurs II $140M
Apr 16, 2021 Versant Vantage II $250M
Dec 17, 2018 Versant Voyageurs I $102.24M
Dec 14, 2018 Versant Venture Capital VII $600M

Investments

Number of Investments
Number of Lead Investments
362
95
Versant Ventures has made 362 investments. Their most recent investment was on Apr 20, 2023, when Abdera Therapeutics raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Series A Biotechnology Yes
Series A $50M Biotechnology Yes
Series A $30M Life Science Yes
Nov 30, 2022 iECURE
Series A $65M Biotechnology
Series C $107M Biotechnology

Employee Profiles

Number of Employee Profiles
31
Versant Ventures has 31 current employee profiles, including Executive Gianni Gromo
Executive
Employee
Executive
Executive

Exits

Versant Ventures has had 100 exits. Versant Ventures most notable exits include AcuFocus ,   Ivantis

Date Company Name Exit Type Industry
Jan 17, 2023 AcuFocus M&A Health Care Detail
Nov 8, 2021 Ivantis M&A Health Care Detail
Oct 21, 2021 Minerva Surgical IPO Health Care Detail
Sep 21, 2021 Gotham Therapeutics M&A Biotechnology Detail
Aug 5, 2021 Vividion Therapeutics M&A Biotechnology Detail